Observational studyMedicine2025

Analysis of risk factors of unfavorable treatment outcomes in patients with rifampicin-sensitive pulmonary tuberculosis.

Luyi Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.